ACCESSWIRE
04 Aug 2022, 00:25 GMT+10
MINNEAPOLIS, MN / ACCESSWIRE / August 3, 2022 / Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for hormonally driven cancers, today announced its participation in the Canaccord Genuity 42nd Annual Growth Conference to be held in Boston on August 8-11, 2022. Brian Sullivan, Chairman, Chief Executive Officer, and Co-founder of Celcuity, is scheduled to present at 11:30 a.m. ET on Wednesday, August 10, 2022.
A live webcast of the presentation will be available using this weblink: https://wsw.com/webcast/canaccord76/celc/2413629. Alternatively, the live webcast will be accessible from the Investors section of the company's website at https://ir.celcuity.com/events-presentations/ with a replay available shortly after the live event.
About Celcuity
Celcuity is a clinical-stage biotechnology company focused on development of targeted therapies for hormonally driven cancers. The company's lead therapeutic candidate is gedatolisib, a potent, reversible dual inhibitor that selectively targets all Class I PI3K isoforms and mTOR. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. The company expects to initiate a Phase 3 study evaluating gedatolisib in patients with HR+/HER2- advanced breast cancer in 2022. Its CELsignia companion diagnostic platform is uniquely able to analyze live patient tumor cells to identify new groups of cancer patients likely to benefit from already approved targeted therapies. Celcuity is headquartered in Minneapolis. Further information about Celcuity can be found at www.celcuity.com.
Contacts:
Celcuity Inc.
Brian Sullivan, bsullivan@celcuity.com
Vicky Hahne, vhahne@celcuity.com
(763) 392-0123
ICR Westwicke
Robert Uhl, robert.uhl@westwicke.com
(619) 228-5886
SOURCE: Celcuity Inc.
Get a daily dose of Illinois Intelligencer news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Illinois Intelligencer.
More InformationMEXICO CITY, Mexico: Rising costs due to inflation resulted in Mexico's manufacturing sector declining in July, despite hopes for a ...
Russia and the United States said on Friday they were ready to discuss a prisoner swap, a day after a ...
His comments come after Washington claimed to have killed Al-Qaeda leader Ayman al-ZawahiriFBI Director Christopher Wray has warned that terrorist ...
The WNBA and NBA issued a joint statement after the women's star was jailed in RussiaBasketball officials in America have ...
Phnom Penh [Cambodia], August 5 (ANI): Amid the controversy surrounding the sentencing of an American basketball player in Russia, the ...
Washington [US], August 5 (ANI): The United States denounced China's missile launches in Japan's exclusive economic zone that were carried ...
Manila, Philippines: Amidst plans to resume an investigation into the Philippines' bloody "War on Drugs," President Ferdinand Marcos Jr ruled ...
LONDON, England: Prosecutors and police have charged a 20-year-old man, arrested in December 2021 with a crossbow while on the ...
BERLIN: Germany: A debate is raging in Germany over whether it should decommission its three remaining nuclear power plants as ...
WELLINGTON, New Zealand: After being shut since March 2020 due to the coronavirus pandemic, New Zealand's borders fully re-opened to ...
TEHRAN, Iran: This week, Iranian media reported that the country's border guards clashed with the Afghan Taliban in the latest ...
LONDON, UK - Myanmar's military has been accused of using Russian-made Yak-130 aircraft with ground attack capability against civilians to ...